Best methods of communicating clinical trial data to improve understanding of treatments for patients with multiple sclerosis od Reen, G, Silber, E, Langdon, D

Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review od Reen, G, Silber, E, Langdon, D

Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review od Reen, G, Silber, E, Langdon, D

Clinical features of headache at altitude: a prospective study. od Silber, E, Sonnenberg, P, Collier, D, Pollard, A, Murdoch, DR, Goadsby, P

Headaches at altitude: Frequency, risk factors, and clinical features od Silber, E, Sonnenberg, P, Pollard, A, Murdoch, DR, Collier, D, Goadsby, P

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY od Jacob, A, Palace, J, Waters, P, Jarius, S, Littleton, E, Malik, M, Nicholas, R, Solomon, T, Silber, E, Constantinescu, C, Vincent, A, Boggild, M